Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT. [electronic resource]
- Clinical genitourinary cancer 10 2017
- e773-e782 p. digital
Publication Type: Journal Article
1938-0682
10.1016/j.clgc.2017.03.009 doi
Aged Aged, 80 and over Androgen Antagonists--therapeutic use Antineoplastic Agents, Hormonal--therapeutic use Choline--administration & dosage Combined Modality Therapy Disease-Free Survival Humans Lymphatic Metastasis Male Middle Aged Neoplasms, Second Primary--diagnostic imaging Positron Emission Tomography Computed Tomography--methods Prostatic Neoplasms--diagnostic imaging Radiosurgery Retrospective Studies Time-to-Treatment Treatment Outcome